window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 3, 2026

  • News
  • About Us
Contact Us

Biopharma

  • Artificial Intelligence,Data Management,Market Access & Commercialization,Technology and platforms

    Most biopharma AI pilots fail to scale, survey warns, as leaders call for stronger data foundations

    A new survey of senior life sciences executives reveals that [...]

    October 25, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy

    Thermo Fisher Scientific accelerates biologic therapeutics development with new CHO K-1 cell line

    October 16, 2025
  • Biomanufacturing,Biotech,Drug Development,Research & Development,Technology and platforms

    Abselion extends Amperia platform with Protein G kit for broader antibody quantification

    Abselion has expanded its Amperia benchtop platform with a new [...]

    September 29, 2025
  • Biologics & Biosimilars,Cell & Gene Therapy,Oncology

    Broken String renews NIST gene editing safety push with INDUCE-seq technology

    Broken String Biosciences has reaffirmed its commitment to supporting the [...]

    August 5, 2025
  • Biologics & Biosimilars,Clinical Development,Drug Development,Movers & Shakers,Research & Development

    Meitheal strengthens leadership team with new chief medical officer and head of medical affairs

    Appointments reflect strategic focus on infectious disease and medical affairs [...]

    August 1, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Market Access & Commercialization,Research & Development

    Nearly three-quarters of scientists expect a recession – but most still plan to spend LINUS survey reveals

    Despite political and economic pressures, researchers remain focused on collaboration, [...]

    July 31, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Data Management,European biotech,Research & Development

    Labguru and Titian Software rebrand as Cenevo to accelerate scientific discovery

    Labguru and Titian Software have rebranded under a unified identity, [...]

    July 31, 2025
  • Biologics & Biosimilars,Clinical Trials,Drug Development,Rare Diseases

    Eleva doses first volunteers with new therapy targeting rare kidney disease

    Dosing of CPV-104 in healthy volunteers marks key milestone in [...]

    July 7, 2025
  • Biologics & Biosimilars,Cell & Gene Therapy

    Cherwell introduces Redipor TwistLock plate range to aid microbial environmental monitoring

    Cleanroom microbiology expert Cherwell, an Analytichem company, has launched a [...]

    June 17, 2025
  • CDMOs & Manufacturing,Partnerships & Funding

    Chrysalis launches following cleanroom asset acquisition and strategic investment

    Chrysalis, a GMP-compliant space and service provider, has formally launched [...]

    June 16, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Skyhawk Therapeutics reports positive nine-month interim results for SKY-0515 in Huntington’s disease
    Categories: Central Nervous System, Clinical Trials, Drug Development, Rare Diseases, Research & Development
  • iOrganBio appoints Karol Jarzabek as chief operating officer
    Categories: Biologics & Biosimilars, Cell & Gene Therapy, Healthcare leadership, Manufacturing, Movers & Shakers, Pharmaceuticals and therapeutics
  • iXCells Biotechnologies partners with Rosebud Biosciences to advance organoid models for rare diseases
    Categories: Biologics & Biosimilars, Cell & Gene Therapy, Clinical Development, Drug Development, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top